B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CSNK2A2

MOLECULAR TARGET

casein kinase 2 alpha 2

UniProt: P19784NCBI Gene: 145912 compounds

CSNK2A2 (casein kinase 2 alpha 2) is targeted by 12 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CSNK2A2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Emodin Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as2.087
2Quercetin1.956
3Apigenin 5,7,4'-trihydroxy-flavone,1.795
4fisetin1.614
5Luteolin 5,7,3',4'-tetrahydroxy-flavone,1.614
6Kaempferols1.393
7myricetin-3-O-galactopyranoside [Supplementary Concept]1.393
8Vanillic Acid1.102
9ly2940021.102
10pictilisib1.102
11chrysin0.691
12Axitinib0.691

About CSNK2A2 as a Drug Target

CSNK2A2 (casein kinase 2 alpha 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 12 compounds with documented CSNK2A2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CSNK2A2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.